Abstract
Resistant hypertension (RH) is a multifactorial disease associated with other clinical conditions such as type 2 diabetes (DM2), obesity and dyslipidemia, as well as target-organ damage, which increases the risk of cardiovascular events. Therefore, new therapeutic strategies in an attempt to achieve blood pressure control and reduce cardiovascular risk of these patients have been studied.…